Although several studies have focused on fibronectin that measured in the plasma of stroke patients, the currently available data does not support their use for distinguishing between ischemic and hemorrhagic stroke (Bustamante et al., 2017), nor to identify patients for recanalizing treatments (Rodríguez-Yáñez et al., 2011). The gene discussed is FN1; the disease is stroke disorder.